Stop Chinese Fentanyl Act of 2025
Chinese chemical companies and government officials who supply or turn a blind eye to ingredients used to make illicit fentanyl face severe U.S. financial penalties under this bill. The President can freeze their U.S.-based assets, bar them from entering the country, and cut them off from doing business with American banks and companies. To monitor the impact of these penalties, the bill requires regular evaluations of their economic costs and effectiveness, while prohibiting broad import bans on regular commercial goods.
What this bill touches.
Who it helps · who it burdens.
Who it helps
- Commercial importers of foreign goodsSection 5(a) explicitly bars the President from using the sanctions authorized or required under the Act to prohibit or restrict the physical importation of commercial goods into the United States.
Who it burdens
- Chinese chemical and drug manufacturing and shipping companiesSection 3(a) expands the legal definition of foreign opioid traffickers subject to U.S. sanctions to include Chinese entities that manufacture, sell, finance, or ship opioid materials without implementing know-your-customer procedures or cooperating with U.S. counternarcotics efforts.
- Senior Chinese government and regulatory officialsSections 3(a) and 3(b)(1) subject Chinese political and regulatory officials to U.S. sanctions if they fail to enforce laws against opioid trafficking, and specifically require the President to evaluate whether the heads of China's police, customs, medical, and narcotics agencies qualify for sanctions.
- Executive Office of the President and federal sanctions administratorsSections 3(b), 4(a), and 4(b)(3) require the President to conduct annual evaluations of emergency economic authorities concerning drug trafficking, extend trafficker reporting obligations to 10 years, and conduct cost-benefit analyses before issuing regulations under the International Emergency Economic Powers Act.
The provisions, in plain language.
Show all 7 provisions
Expands U.S. sanctions against foreign opioid traffickers to include Chinese companies that make, sell, or ship opioid materials without safeguards, as well as Chinese government officials who fail to enforce laws against those companies.
Requires the President to explicitly determine whether the heads of China's top drug control, police, customs, and medical regulatory agencies qualify as foreign opioid traffickers subject to sanctions.
Requires the President, when issuing economic emergency regulations regarding international drug trafficking, to analyze costs and benefits, consider alternatives, and define conditions for ending the emergency.
Prohibits the President from using sanctions under this Act to ban or restrict the physical importation of commercial goods into the United States.
Urges the Chinese government to tighten regulation of chemical shipments, require know-your-customer rules, coordinate with the United States on precursor chemicals, and strictly enforce rules against drug trafficking.
Extends the President's requirement to submit an annual report to Congress identifying foreign opioid traffickers subject to sanctions from 5 years to 10 years.
Requires the President to send annual reports to Congress evaluating how effectively emergency economic powers are working to address international drug trafficking, including feedback from the public and private sectors.
Expands U.S. sanctions against foreign opioid traffickers to include Chinese companies that make, sell, or ship opioid materials without safeguards, as well as Chinese government officials who fail to enforce laws against those companies.
Requires the President to explicitly determine whether the heads of China's top drug control, police, customs, and medical regulatory agencies qualify as foreign opioid traffickers subject to sanctions.
Requires the President, when issuing economic emergency regulations regarding international drug trafficking, to analyze costs and benefits, consider alternatives, and define conditions for ending the emergency.
Prohibits the President from using sanctions under this Act to ban or restrict the physical importation of commercial goods into the United States.
How your members of Congress line up
How members voted on Stop Chinese Fentanyl Act of 2025.
Recorded roll calls on this bill, most recent first. Open one to see each member's position.
How it moved.
Show all 16 actions
- Received in the Senate and Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
- Motion to reconsider laid on the table Agreed to without objection.
- On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 407 - 4 (Roll no. 220). (text: CR H3728-3729)
- Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 407 - 4 (Roll no. 220).
- Considered as unfinished business. (consideration: CR H3741-3742)
- At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
- DEBATE - The House proceeded with forty minutes of debate on H.R. 747.
- Considered under suspension of the rules. (consideration: CR H3728-3731)
- Mr. Baumgartner moved to suspend the rules and pass the bill, as amended.
- Ordered to be Reported in the Nature of a Substitute by Voice Vote.
- Committee Consideration and Mark-up Session Held
- Reported (Amended) by the Committee on Financial Services. H. Rept. 119-19, Part I.
- Ordered to be Reported (Amended) by the Yeas and Nays: 49 - 0.
- Committee Consideration and Mark-up Session Held
- Referred to the Committee on Foreign Affairs, and in addition to the Committees on Financial Services, Oversight and Government Reform, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Introduced in House
- Received in the Senate and Read twice and referred to the Committee on Banking, Housing, and Urban Affairs.
- Motion to reconsider laid on the table Agreed to without objection.
- On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 407 - 4 (Roll no. 220). (text: CR H3728-3729)
- Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 407 - 4 (Roll no. 220).
- Ordered to be Reported in the Nature of a Substitute by Voice Vote.
- Reported (Amended) by the Committee on Financial Services. H. Rept. 119-19, Part I.
- Ordered to be Reported (Amended) by the Yeas and Nays: 49 - 0.
- Introduced in House
Read it for yourself.
Sources & provenance
Cite this page
Civic Herald. “Stop Chinese Fentanyl Act of 2025 (H.R. 747, 119th Congress).” https://civicherald.app/bills/119-hr-747. Congress.gov record as of Jul 13, 2026.